摘要
目的调查分析本院2型糖尿病患者的药物应用经济学情况。方法将本院2012年1～12月收治的100例2型糖尿病患者，根据治疗药物应用的不同分为治疗组与对照组，每组各50例，对照组应用甘精胰岛素、门冬胰岛素、精蛋白生物合成人胰岛素注射液混合治疗，治疗组应用门冬胰岛素30注射液治疗。结果对照组有效率为94．0％，治疗组有效率为98．0％，两组有效率比较差异无统计学意义（P〉0.05）：对照组的药物成本明显高于治疗组（P〈0.05），对照组的成本效果值明显高于治疗组（P〈0.05）。结论2型糖尿病患者要积极应用胰岛素治疗，其中门冬胰岛素30注射液的应用能取得更好的药物应用经济学效果，值得推广应用。
Objective To investigate and analysis the situation of drug applied economics analysis for diabetes patients in our hospi!al. Methods 100 patients with type 2 diabetes from Jan 2012 to Dec accorded to the application of different therapeutic drugs were equally divided into the treatment group and the control group,the control group were given insulin glargine,insulin aspart,isophane protamine biosynthetic human insulin mixed treatment,and the treatment group were given the insulin aspart 30 treatment. Results The response rate was 94.0% in control group,so that was 98.0% in the treatment group （P〉0.05）,but the drug costs of the control group was significantly higher than the cost of the treatment group （P〈0.05）,while the cost-effectiveness values of the control group was significantly higher than that in the treatment group （P〈0.05）. Conclusion Diabetic patients should actively given the insulin therapy,the aspart 30 injection applications can achieve better drug applied economics that should be widely applied.
出处
《中国当代医药》
2013年第30期136-137,142,共3页
China Modern Medicine
